Nota de los editores
Neurología y psiquiatría: disciplinas complementarias
Dr. Juan E. Mezzich y Dr. Miguel R. Jorge
En vivo desde Nueva York, les presentamos Psiquiatría y Salud Integral
Nota del editor invitado
Psiquiatría infantil en América Latina: gran demanda
Dr. Carlos E. Berganza
Novel Mechanisms in the Future of Cancer Treatment: Angiogenesis & Signal Transduction
MODERATOR: Michael Goldstein, MD
DISCUSSANTS: Roy S. Herbst, MD, PhD, and Michael S. Gordon, MD
Obsessive-Compulsive Disorder: Implications of the Efficacy of an SSRI, Paroxetine
By Philip T. Ninan, MD
Off-Label Second Generation Antipsychotics for Impulse Regulation Disorders: A Review
Albertine Scheltema Beduin, Lieuwe de Haan
Oncology Ethics Forum
Ethical Perspectives on Oncology Care
By Terri Maxwell, RN, MSN, AOCN
The Expanding Indications for Preimplantation Genetic Diagnosis
By Steven Joffe, MD, MPH
Opciones fármacoterapéuticas en el tratamiento de la depresión y ansiedad comórbidas
Dr. Mark H. Pollack y Patricia C. Marzol
Opium Withdrawal Delirium: Two Case Reports
By Ravi C. Sharma, Ramesh Kumar, Dinesh Dutt Sharma, Pankaj Kanwar
Optimizing Treatment Outcomes for Patients With Depression and Generalized Anxiety Disorder
By Michael E. Thase, MD, and Madhukar Trivedi, MD
Our Current Understanding of Genetic Alterations in Colorectal Cancer, and Implications for Clinical Use
By Manel Esteller, MD, PhD, and Montserrat Sanchez-Cespedes, PhD
Evidence-Based Medicine
Paliperidone Palmitate Treatment in Outpatient Care Setting: A Naturalistic Study
By Rosaria Di Lorenzo, Michela Cameli, Marisa Bolondi, Giulia Landi, Valentina Moretti, Chiara Piemonte, Gabriella Pollutri
Palliative Care Options for Advanced Prostate Cancer
By Amir V. Kaisary, MA, ChM, FRCS, and Ross Knight, MRCS
Palliative Chemotherapy for Advanced Colorectal Cancer
By Peter Simmonds, FRACP, and Tim Iveson, MD
Panel Discussion
Panic Disorder During Pregnancy
By Dana March, BA and Kimberly A. Yonkers, MD
Paroxetine Treatment of Depression in Late Life
By Charles F. Reynolds III, MD
Paroxetine Treatment of Generalized Anxiety Disorder
By David V. Sheehan, MD, MBA, and C. Gloria Mao, PharmD
Paroxetine Treatment of Major Depressive Disorder
By Martin B. Keller, MD
Paroxetine Treatment of Mood and Anxiety Disorders in Children and Adolescents
By Karen Dineen Wagner, MD, PhD
Paroxetine Treatment of Mood Disorders in Women: Premenstrual Dysphoric Disorder and Hot Flashes
By Kimberly A. Yonkers, MD
Paroxetine Use in Medically Ill Patients
By Steven Stout, MD, PhD, Wendy I. Somerset, MD, Andrew Miller, MD, and Dominique L. Musselman, MD, MS
Paroxetine—The Antidepressant from Hell? Probably Not, But Caution Required
By Robert M. Nevels, Samuel T. Gontkovsky, Bryman E. Williams
Patient Outcomes With Education, Drug Therapy, and Support: A Study of Venlafaxine ER-Treated Outpatients with Major Depressive Disorder
By Kasia Lobello, Sujana Reddy, Jeff Musgnung, Ronald Pedersen, Philip T. Ninan
Perfíl biográfico
Acerdándose a la salud mental fuera del consultorio: un perfil del Dr. Jaime Arroyo
Dr. Eduardo Gastelumendi D’Argent